HK1206339A1 - N-aryltriazole compounds as lpar antagonists lpar n- - Google Patents

N-aryltriazole compounds as lpar antagonists lpar n-

Info

Publication number
HK1206339A1
HK1206339A1 HK15106924.1A HK15106924A HK1206339A1 HK 1206339 A1 HK1206339 A1 HK 1206339A1 HK 15106924 A HK15106924 A HK 15106924A HK 1206339 A1 HK1206339 A1 HK 1206339A1
Authority
HK
Hong Kong
Prior art keywords
lpar
antagonists
aryltriazole
compounds
aryltriazole compounds
Prior art date
Application number
HK15106924.1A
Other languages
English (en)
Chinese (zh)
Inventor
斯蒂芬．迪姆斯．加布里埃爾
馬修．邁克爾．漢密爾頓
錢義民
阿奇尤特哈拉.西杜瑞
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48628669&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1206339(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1206339A1 publication Critical patent/HK1206339A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK15106924.1A 2012-06-20 2015-07-21 N-aryltriazole compounds as lpar antagonists lpar n- HK1206339A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261661953P 2012-06-20 2012-06-20
PCT/EP2013/062463 WO2013189865A1 (fr) 2012-06-20 2013-06-17 Composés n-aryltriazole utilisés comme antagonistes de lpar

Publications (1)

Publication Number Publication Date
HK1206339A1 true HK1206339A1 (en) 2016-01-08

Family

ID=48628669

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15106924.1A HK1206339A1 (en) 2012-06-20 2015-07-21 N-aryltriazole compounds as lpar antagonists lpar n-

Country Status (22)

Country Link
US (1) US20150133512A1 (fr)
EP (1) EP2864301A1 (fr)
JP (1) JP2015520203A (fr)
KR (1) KR20150011389A (fr)
CN (1) CN104395299A (fr)
AU (1) AU2013279513A1 (fr)
BR (1) BR112014030674A2 (fr)
CA (1) CA2869564A1 (fr)
CL (1) CL2014003241A1 (fr)
CO (1) CO7131357A2 (fr)
EA (1) EA201492281A1 (fr)
HK (1) HK1206339A1 (fr)
IL (1) IL236087A0 (fr)
IN (1) IN2014DN09352A (fr)
MA (1) MA37762B1 (fr)
MX (1) MX2014014711A (fr)
PE (1) PE20142305A1 (fr)
PH (1) PH12014502363A1 (fr)
SG (1) SG11201407228PA (fr)
UA (1) UA110310C2 (fr)
WO (1) WO2013189865A1 (fr)
ZA (1) ZA201408167B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013025733A1 (fr) 2011-08-15 2013-02-21 Intermune, Inc. Antagonistes des récepteurs d'acide lysophosphatidique
TW201437200A (zh) * 2013-01-15 2014-10-01 Intermune Inc 溶血磷脂酸受體拮抗劑
US10000459B2 (en) 2013-03-15 2018-06-19 Epigen Biosciences, Inc. Heterocyclic compounds useful in the treatment of disease
UY36060A (es) 2014-04-02 2015-10-30 Bayer Pharma AG Compuestos de azol sustituidos con amida
RU2689315C2 (ru) 2014-06-27 2019-05-27 Убе Индастриз, Лтд. Соль гетероциклического соединения, замещенного галогеном
WO2017055316A1 (fr) 2015-10-01 2017-04-06 Bayer Pharma Aktiengesellschaft Composés azole à substitution amido
WO2017055313A1 (fr) 2015-10-01 2017-04-06 Bayer Pharma Aktiengesellschaft Composés azole amido-substitués
AR108838A1 (es) 2016-06-21 2018-10-03 Bristol Myers Squibb Co Ácidos de carbamoiloximetil triazol ciclohexilo como antagonistas de lpa
WO2018078009A1 (fr) 2016-10-29 2018-05-03 Bayer Pharma Aktiengesellschaft Dérivés de cyclohexane à substitution amido
WO2018078005A1 (fr) 2016-10-29 2018-05-03 Bayer Pharma Aktiengesellschaft Dérivés d'azaspiro à substitution amido en tant qu'inhibiteurs de tankyrase
WO2018087126A1 (fr) 2016-11-09 2018-05-17 Bayer Pharma Aktiengesellschaft Dérivés de cyclohexane à substitution amido en tant qu'inhibiteurs de tankyrase
CN107721984A (zh) * 2017-11-07 2018-02-23 大连理工大学 一种新型5‑酰胺基‑1,4,5‑三取代的1,2,3‑三氮唑的制备方法
CN107827829A (zh) * 2017-11-07 2018-03-23 大连理工大学 5‑酰胺基‑1,4,5‑三取代的1,2,3‑三氮唑在水相及生物介质中的制备方法
EP3728223B1 (fr) 2017-12-19 2022-12-28 Bristol-Myers Squibb Company Azines triazoles d'acide cyclohexyle utilisées en tant qu'antagonistes de lpa
JP7299892B2 (ja) 2017-12-19 2023-06-28 ブリストル－マイヤーズ スクイブ カンパニー Ｌｐａアンタゴニストとしてのシクロヘキシル酸ピラゾールアジン
US11261180B2 (en) 2017-12-19 2022-03-01 Bristol-Myers Squibb Company Cyclohexyl acid isoxazole azoles as LPA antagonists
EP3728240B1 (fr) * 2017-12-19 2022-06-29 Bristol-Myers Squibb Company Acides carbamoyle cyclohexyliques à liaison o isoxazole utilisés en tant qu'antagonistes de lpa
WO2019126086A1 (fr) * 2017-12-19 2019-06-27 Bristol-Myers Squibb Company Azines isoxazole d'acide de cyclohexyle en tant qu'antagonistes de lpa
EP3727589B1 (fr) 2017-12-19 2022-06-29 Bristol-Myers Squibb Company Acides pyrazoles azoles cyclohexyliques utilisés en tant qu'antagonistes de lpa
KR20200100724A (ko) 2017-12-19 2020-08-26 브리스톨-마이어스 스큅 컴퍼니 Lpa 길항제로서의 이속사졸 n-연결된 카르바모일 시클로헥실 산
US11319315B2 (en) 2017-12-19 2022-05-03 Bristol-Myers Squibb Company Cyclohexyl acid triazole azoles as LPA antagonists
EP3728196B1 (fr) 2017-12-19 2023-04-05 Bristol-Myers Squibb Company Acides carbamoyle cyclohexyliques à liaison o pyrazole utilisés en tant qu'antagonistes de lpa
ES2962367T3 (es) 2017-12-19 2024-03-18 Bristol Myers Squibb Co Acidos carbamoil ciclohexílicos N-enlazados a pirazol como antagonistas de receptores del ácido lisofosfatídico (LPA)
CN111434653A (zh) * 2019-01-15 2020-07-21 武汉朗来科技发展有限公司 三氮唑类化合物及其制备方法与用途
AU2020384883B2 (en) 2019-11-15 2023-11-16 Gilead Sciences, Inc. Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereof
TW202344504A (zh) 2020-06-03 2023-11-16 美商基利科學股份有限公司 Lpa受體拮抗劑及其用途
CN115867556A (zh) 2020-06-03 2023-03-28 吉利德科学公司 Lpa受体拮抗剂及其用途
US11939318B2 (en) 2021-12-08 2024-03-26 Gilead Sciences, Inc. LPA receptor antagonists and uses thereof
CN115745848A (zh) * 2022-12-07 2023-03-07 上海优合生物科技有限公司 一种氨基胍的加工合成工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011159550A2 (fr) * 2010-06-14 2011-12-22 Amidra Pharmaceuticals, Inc. Antagoniste du récepteur de l'acide lysophosphatidique et ses utilisations
WO2011159633A1 (fr) * 2010-06-15 2011-12-22 Amira Pharmaceuticals, Inc. Formulations inhalables d'antagonistes de récepteur d'acide lysophosphatidique
WO2012078593A2 (fr) * 2010-12-07 2012-06-14 Amira Pharmaceuticals, Inc. Antagonistes des récepteurs de l'acide lysophosphatidique et utilisations de ceux-ci
WO2012138648A1 (fr) * 2011-04-06 2012-10-11 Irm Llc Compositions et procédés pour la modulation de récepteurs au lpa
WO2013025733A1 (fr) * 2011-08-15 2013-02-21 Intermune, Inc. Antagonistes des récepteurs d'acide lysophosphatidique
IN2014DN09348A (fr) * 2012-06-20 2015-07-17 Hoffmann La Roche

Also Published As

Publication number Publication date
IN2014DN09352A (fr) 2015-07-17
MA37762A1 (fr) 2017-07-31
WO2013189865A1 (fr) 2013-12-27
CO7131357A2 (es) 2014-12-01
KR20150011389A (ko) 2015-01-30
SG11201407228PA (en) 2014-12-30
CN104395299A (zh) 2015-03-04
CA2869564A1 (fr) 2013-12-27
EA201492281A1 (ru) 2015-04-30
US20150133512A1 (en) 2015-05-14
UA110310C2 (uk) 2015-12-10
PH12014502363A1 (en) 2015-01-12
MA37762B1 (fr) 2018-04-30
PE20142305A1 (es) 2015-01-16
AU2013279513A1 (en) 2014-10-16
JP2015520203A (ja) 2015-07-16
EP2864301A1 (fr) 2015-04-29
IL236087A0 (en) 2015-02-01
ZA201408167B (en) 2015-12-23
CL2014003241A1 (es) 2015-03-20
MX2014014711A (es) 2015-03-04
BR112014030674A2 (pt) 2017-06-27

Similar Documents

Publication Publication Date Title
HK1206339A1 (en) N-aryltriazole compounds as lpar antagonists lpar n-
HK1206342A1 (en) N-alkyltriazole compounds as lpar antagonists lpar n-
HK1201819A1 (en) Novel compounds
GB201207406D0 (en) Novel compounds
HK1212985A1 (zh) 新化合物
EP2922550A4 (fr) Nouveaux composés
HK1208826A1 (en) Novel compounds
GB201212871D0 (en) Novel compounds
HK1206341A1 (en) Substituted pyrazole compounds as lpar antagonists lpar
EP2922547A4 (fr) Nouveaux composés
IL280595A (en) new compounds
GB201209986D0 (en) Novel compounds
GB201222711D0 (en) Novel compounds
GB201207392D0 (en) Novel compounds
GB201209670D0 (en) Novel compounds
GB201212816D0 (en) Novel compounds
GB201222433D0 (en) Novel compounds
GB201222419D0 (en) Novel compounds
GB201222430D0 (en) Novel compounds
GB201222435D0 (en) Novel compounds
GB201222393D0 (en) Novel compounds
GB201219554D0 (en) Novel compounds
GB201219472D0 (en) Novel compounds
GB201217387D0 (en) Novel compounds
GB201216551D0 (en) Novel compounds